,,
By using this website you allow us to place cookies on your computer. Please read our Privacy Policy for more details.
Publication Date: August 2008
Publisher: Mathematica Policy Research, Inc.
Author(s): James Verdier; Ann Bagchi; Dominick Esposito
Research Area: Health
Keywords: Medicare Part D; Dual Eligibles; Medicaid; Prescription Drug
Type: Brief
Coverage: United States
Abstract:
New data, prepared for the Centers for Medicare & Medicaid Services, provide detailed state-by-state and national information on prescription drug cost and utilization in 2003 for Medicaid beneficiaries enrolled in both Medicaid and Medicare ("dual eligibles"), whose drug coverage shifted from Medicaid to Medicare Part D in 2006.
This brief highlights key data on drug use and spending in 2003 for dual eligibles, as well as Part D issues that these data can help to inform. Sixty-five percent of the 6.7 million dual eligibles who received drug coverage from Medicaid in 2003 were age 65 or older; the rest were under 65 and disabled. Among dual eligibles as a whole, the most costly drug group was antipsychotics, accounting for over $2.3 billion in expenditures in 2003. Ulcer drugs were the next most costly group ($1.38 billion), followed by antidepressants ($1.18 billion).